Nemetscheks, Analyst

Nemetschek's Analyst Divide Widens to 63 Euros as HCSS Integration Costs Bite

Published on 08/06/2026 at 19:32 | Redaktion boerse-global.de

Wall Street divided on Nemetschek as UBS cuts to Sell with 52-euro target, JPMorgan holds 110-euro Overweight; insider buying adds intrigue.

Nemetschek Stock Split: UBS Sell vs JPMorgan Buy Amid Margin Concerns
Nemetschek's Analyst Divide Widens to 63 Euros as HCSS Integration Costs Bite Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de

The gap between Wall Street's most bullish and bearish views on Nemetschek has never been wider. UBS now tells clients to sell the Munich-based construction software group with a 52-euro price target, while JPMorgan stands by an 110-euro target and an "Overweight" rating — a spread of nearly 63 euros on a stock that currently trades at roughly 57 euros. That extraordinary divergence captures the central tension: a company delivering double-digit growth while its share price sits almost 59 percent below last summer's peak.

Growth That Costs

The numbers themselves tell a story of operational strength. For the second quarter of 2026, Nemetschek reported currency-adjusted revenue growth of 14.5 percent to 327.7 million euros, with subscription and SaaS revenues surging 29.6 percent to 266.4 million euros. Adjusted EBITDA rose 15.8 percent on a currency-neutral basis to 98.6 million euros, with the reported margin coming in at 30.1 percent and the acquisition-adjusted figure at 31.0 percent.

Management had already laid out the full-year framework two days before the earnings release, confirming guidance for organic, currency-adjusted growth of 14 to 15 percent. The consolidation of HCSS — the US construction software specialist acquired on July 1 — is expected to add roughly 600 basis points to revenue. But that growth comes at a price: management anticipates margin dilution of approximately 150 basis points, with full-year EBITDA margin guided at 32 to 33 percent before that hit.

That dilution is precisely what has split the analyst community down the middle.

Should investors sell immediately? Or is it worth buying Nemetschek?

A House Divided

UBS formally downgraded the stock from "Neutral" to "Sell" this week, trimming its price target from 53 to 52 euros. The Swiss bank cited concerns about earnings quality and unfavorable currency effects. It was the latest in a series of target cuts following the quarterly results and the early stages of the HCSS integration.

The optimists see the same facts through a different lens. JPMorgan reaffirmed its 110-euro target and "Overweight" stance on the day of the earnings release. Berenberg holds a "Buy" rating with a 115-euro target. Barclays trimmed its target from 85 to 80 euros at the end of July but kept "Overweight." mwb research reiterated its buy recommendation on Monday, though it lowered its target from 91 to 89 euros, citing the short-term margin pressure from integration costs. Jefferies sits in the middle with a "Hold" and a 70-euro target, explicitly flagging the near-term EBITDA drag from one-off items.

The bull camp's targets cluster between roughly 80 and 90 euros — comfortably above the current share price — while UBS's 52 euros sits dangerously close to where the stock actually trades.

Insider Buying Offers a Counterpoint

Adding a curious wrinkle to the UBS downgrade: supervisory board member Kurt Dobitsch purchased Nemetschek shares worth 91,650 euros on Monday. Insider purchases are often read as a signal that those closest to the company consider the current valuation attractive — a quiet vote of confidence that sits awkwardly against the Swiss bank's sell recommendation.

A Stock in Freefall

The market's verdict so far favors the bears. The shares closed Wednesday at 56.70 euros, down 2.16 percent on the day, and have lost 4.13 percent over the past seven trading sessions. The current price of 56.85 euros stands roughly 59 percent below the 52-week high of 138.60 euros reached last August — a decline of such magnitude that operational metrics alone struggle to explain it.

Nemetschek at a turning point? This analysis reveals what investors need to know now.

The Bigger Bet

Beyond the quarterly noise lies a strategic transformation. Nemetschek unveiled its "Engineering Days 2026" program roughly two weeks ago, centered on embedding artificial intelligence into the precast concrete industry and the launch of "Bluebeam Max," an AI suite introduced on May 20 that aims to bring agent-based intelligence into construction workflows.

The construction sector remains one of the least digitized industries globally, and Nemetschek's positioning as a consolidator — with HCSS as the latest piece — reflects a deliberate bet on structural change. The question investors must answer is whether the current margin squeeze is a temporary indigestion following a major acquisition or a more fundamental problem with the story. For now, the market is voting with its feet, and the stock's trajectory suggests the integration of HCSS and the path of the adjusted margin over the coming quarters will determine which side of the analyst divide ultimately proves right.

Ad

Nemetschek Stock: New Analysis - 6 August

Fresh Nemetschek information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Nemetschek analysis...

Disclaimer...

en | DE0006452907 | NEMETSCHEKS | boerse | 69923711 |